comparemela.com
Home
Live Updates
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets : comparemela.com
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...
Related Keywords
Germany
,
New York
,
United States
,
Massachusetts
,
Cambridge
,
Cambridgeshire
,
United Kingdom
,
Singapore
,
Spain
,
South Korea
,
Paris
,
France General
,
France
,
Thailand
,
China
,
Texas
,
Ligia Vela Reid
,
Brandon Owens
,
Pierre Louis Germain
,
Janssen Lianbio
,
Drug Administration
,
Linkedin
,
Investor Relations Department
,
Lianbio Assigns Development Rights To Janssen
,
Euronext
,
French Financial Markets Authority Autorit
,
Exchange Commission
,
Johnson
,
Twitter
,
Communications Department
,
University Of Texas Md Anderson Cancer Center
,
Nasdaq
,
Given The Company
,
Janssen Pharmaceutica
,
Laurent Levy
,
United States Food
,
Fast Track
,
Cancer Center
,
Nasdaq Global Select Market
,
New York City
,
Private Securities Litigation Reform Act
,
Annual Report
,
French Financial Markets Authority
,
Des March
,
Bio Assigns Development Rights
,
Markets
,
comparemela.com © 2020. All Rights Reserved.